Research ArticleOriginal Article
Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
Meiting Chen
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Zhao Wang
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Xiaojie Fang
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Yuyi Yao
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Quanguang Ren
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Zegeng Chen
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Ying Tian
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Fei Pan
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Xiaoqian Li
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Zhiming Li
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Qingqing Cai
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
He Huang
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
Tongyu Lin
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
2Senior Ward/Phase I Clinical Trial Ward, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China
References
- 1.↵
- Casulo C,
- Friedberg J.
- 2.↵
- Mead GM,
- Sydes MR,
- Walewski J,
- Grigg A,
- Hatton CS,
- Norbert P, et al.
- 3.↵
- Magrath I,
- Adde M,
- Shad A,
- Venzon D,
- Seibel N,
- Gootenberg J, et al.
- 4.↵
- Mead GM,
- Barrans SL,
- Qian W,
- Walewski J,
- Radford JA,
- Wolf M, et al.
- 5.↵
- 6.↵
- Ribrag V,
- Koscielny S,
- Bosq J,
- Leguay T,
- Casasnovas O,
- Fornecker L-M, et al.
- 7.↵
- Dunleavy K,
- Pittaluga S,
- Shovlin M,
- Steinberg SM,
- Cole D,
- Grant C, et al.
- 8.↵
- Zuze T,
- Ellis GK,
- Kasonkanji E,
- Kaimila B,
- Nyasosela R,
- Nyirenda R, et al.
- 9.↵
- 10.↵
- Rizzieri D,
- Johnson J,
- Byrd J,
- Lozanski G,
- Blum K,
- Powell B, et al.
- 11.↵
- Cheson BD,
- Fisher RI,
- Barrington SF,
- Cavalli F,
- Schwartz LH,
- Zucca E, et al.
- 12.↵
- Ye Z,
- Xiao Y,
- Shi H,
- Ke Z,
- Liu Y,
- Liang Y, et al.
- 13.↵
- Jacobson C,
- LaCasce A.
- 14.↵
- Costa LJ,
- Xavier AC,
- Wahlquist AE,
- Hill EG.
- 15.↵Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version). Chin J Cancer Res. 2019;31:557–77.
- 16.↵
- Lacasce A,
- Howard O,
- Li S,
- Fisher D,
- Weng A,
- Neuberg D, et al.
- 17.↵
- Noy A,
- Lee JY,
- Cesarman E,
- Ambinder R,
- Baiocchi R,
- Reid E, et al.
- 18.↵
- 19.↵
- Yang X,
- Huang Q,
- Li A,
- Chen Y,
- Xu W,
- Li J, et al.
In this issue
Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang, Tongyu Lin
Cancer Biology & Medicine Aug 2021, 18 (3) 833-840; DOI: 10.20892/j.issn.2095-3941.2020.0314
Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang, Tongyu Lin
Cancer Biology & Medicine Aug 2021, 18 (3) 833-840; DOI: 10.20892/j.issn.2095-3941.2020.0314
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.